William Oh

View Scopus Profile

William Oh

MD

Calculated based on number of publications stored in Pure and citations from Scopus
19982023

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Headline

CHIEF | Tisch Cancer Institute PROFESSOR | Medicine, Hematology and Medical Oncology PROFESSOR | Urology

Biography

William K. Oh, M.D. is the Chief of the Division of Hematology and Medical Oncology; Professor of Medicine and Urology; and Ezra M. Greenspan, MD Professor in Clinical Cancer Therapeutics at the Mount Sinai School ofMedicine and Associate Director for Clinical Research, The Tisch Cancer Institute. Clinical Interests: Management of genitourinary malignancies, including prostate, renal, bladder, adrenocortical and testicular cancers. Research Interests: Dr. Oh's research interests include exploring the role of chemotherapy in both castration-resistant prostate cancer (CRPC) and localized high-risk prostate cancer. In collaboration with laboratory-based colleagues, we are assessing changes in the expression of tissue and serum biomarkers due to chemotherapy. Another area of interest relates to the role of secondary hormone therapies in the treatment of advanced prostate cancer. Another major research area has been the development and management of a prospective clinical database linked to blood and tissue banks for prostate cancer patients. Dr. Oh's recent research efforts exploring this database have included characterization of the efficacy of various therapies in advanced prostate cancer (e.g., nilutamide, ketoconazole, vinorelbine, docetaxel, mitoxantrone), assessment of PSA doubling time as a prognostic and predictive factor, efficacy of hormonal therapy, assessment of testosterone as a marker for cancer outcome, prediction of relapse based on nutritional factors at diagnosis and autoantibody signatures, and assessment of pharmacogenomic patterns predicting Gleason score.

Fingerprint

Dive into the research topics where William Oh is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles
View full fingerprint

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Explore network further

  • Biomarker Development Trial of Satraplatin in Patients with Metastatic Castration-Resistant Prostate Cancer

    Liaw, B. C., Tsao, C. K., Seng, S., Jun, T., Gong, Y., Galsky, M. D. & Oh, W. K., 6 Apr 2023, In: Oncologist. 28, 4, p. 366-e224

    Research output: Contribution to journal › Article › peer-review

    Open Access

  • Effect of concurrent beta-blocker use in patients receiving immune checkpoint inhibitors for advanced solid tumors

    Mellgard, G., Patel, V. G., Zhong, X., Joshi, H., Qin, Q., Wang, B., Parikh, A., Jun, T., Alerasool, P., Garcia, P., Gogerly-Moragoda, M., Leiter, A., Gallagher, E. J., Oh, W. K., Galsky, M. D. & Tsao, C. K., Jul 2023, In: Journal of Cancer Research and Clinical Oncology. 149, 7, p. 2833-2841 9 p.

    Research output: Contribution to journal › Article › peer-review

    4 Scopus citations

  • Management of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022

    Gillessen, S., Bossi, A., Davis, I. D., de Bono, J., Fizazi, K., James, N. D., Mottet, N., Shore, N., Small, E., Smith, M., Sweeney, C., Tombal, B., Antonarakis, E. S., Aparicio, A. M., Armstrong, A. J., Attard, G., Beer, T. M., Beltran, H., Bjartell, A., Blanchard, P., & 98 othersBriganti, A., Bristow, R. G., Bulbul, M., Caffo, O., Castellano, D., Castro, E., Cheng, H. H., Chi, K. N., Chowdhury, S., Clarke, C. S., Clarke, N., Daugaard, G., De Santis, M., Duran, I., Eeles, R., Efstathiou, E., Efstathiou, J., Ngozi Ekeke, O., Evans, C. P., Fanti, S., Feng, F. Y., Fonteyne, V., Fossati, N., Frydenberg, M., George, D., Gleave, M., Gravis, G., Halabi, S., Heinrich, D., Herrmann, K., Higano, C., Hofman, M. S., Horvath, L. G., Hussain, M., Jereczek-Fossa, B. A., Jones, R., Kanesvaran, R., Kellokumpu-Lehtinen, P. L., Khauli, R. B., Klotz, L., Kramer, G., Leibowitz, R., Logothetis, C. J., Mahal, B. A., Maluf, F., Mateo, J., Matheson, D., Mehra, N., Merseburger, A., Morgans, A. K., Morris, M. J., Mrabti, H., Mukherji, D., Murphy, D. G., Murthy, V., Nguyen, P. L., Oh, W. K., Ost, P., O'Sullivan, J. M., Padhani, A. R., Pezaro, C., Poon, D. M. C., Pritchard, C. C., Rabah, D. M., Rathkopf, D., Reiter, R. E., Rubin, M. A., Ryan, C. J., Saad, F., Pablo Sade, J., Sartor, O. A., Scher, H. I., Sharifi, N., Skoneczna, I., Soule, H., Spratt, D. E., Srinivas, S., Sternberg, C. N., Steuber, T., Suzuki, H., Sydes, M. R., Taplin, M. E., Tilki, D., Türkeri, L., Turco, F., Uemura, H., Uemura, H., Ürün, Y., Vale, C. L., van Oort, I., Vapiwala, N., Walz, J., Yamoah, K., Ye, D., Yu, E. Y., Zapatero, A., Zilli, T. & Omlin, A., Mar 2023, In: European Urology. 83, 3, p. 267-293 27 p.

    Research output: Contribution to journal › Article › peer-review

    Open Access
    12 Scopus citations

  • Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

    Gillessen, S., Bossi, A., Davis, I. D., de Bono, J., Fizazi, K., James, N. D., Mottet, N., Shore, N., Small, E., Smith, M., Sweeney, C. J., Tombal, B., Antonarakis, E. S., Aparicio, A. M., Armstrong, A. J., Attard, G., Beer, T. M., Beltran, H., Bjartell, A., Blanchard, P., & 98 othersBriganti, A., Bristow, R. G., Bulbul, M., Caffo, O., Castellano, D., Castro, E., Cheng, H. H., Chi, K. N., Chowdhury, S., Clarke, C. S., Clarke, N., Daugaard, G., De Santis, M., Duran, I., Eeles, R., Efstathiou, E., Efstathiou, J., Ekeke, O. N., Evans, C. P., Fanti, S., Feng, F. Y., Fonteyne, V., Fossati, N., Frydenberg, M., George, D., Gleave, M., Gravis, G., Halabi, S., Heinrich, D., Herrmann, K., Higano, C., Hofman, M. S., Horvath, L. G., Hussain, M., Jereczek-Fossa, B. A., Jones, R., Kanesvaran, R., Kellokumpu-Lehtinen, P. L., Khauli, R. B., Klotz, L., Kramer, G., Leibowitz, R., Logothetis, C., Mahal, B., Maluf, F., Mateo, J., Matheson, D., Mehra, N., Merseburger, A., Morgans, A. K., Morris, M. J., Mrabti, H., Mukherji, D., Murphy, D. G., Murthy, V., Nguyen, P. L., Oh, W. K., Ost, P., O'Sullivan, J. M., Padhani, A. R., Pezaro, C. J., Poon, D. M. C., Pritchard, C. C., Rabah, D. M., Rathkopf, D., Reiter, R. E., Rubin, M. A., Ryan, C. J., Saad, F., Sade, J. P., Sartor, O., Scher, H. I., Sharifi, N., Skoneczna, I., Soule, H., Spratt, D. E., Srinivas, S., Sternberg, C. N., Steuber, T., Suzuki, H., Sydes, M. R., Taplin, M. E., Tilki, D., Türkeri, L., Turco, F., Uemura, H., Uemura, H., Ürün, Y., Vale, C. L., van Oort, I., Vapiwala, N., Walz, J., Yamoah, K., Ye, D., Yu, E. Y., Zapatero, A., Zilli, T. & Omlin, A., May 2023, In: European Journal of Cancer. 185, p. 178-215 38 p.

    Research output: Contribution to journal › Article › peer-review

    Open Access
    6 Scopus citations

  • Clinical factors associated with outcome in solid tumor patients treated with immune-checkpoint inhibitors: a single institution retrospective analysis

    Qin, Q., Jun, T., Wang, B., Patel, V. G., Mellgard, G., Zhong, X., Gogerly-Moragoda, M., Parikh, A. B., Leiter, A., Gallagher, E. J., Alerasool, P., Garcia, P., Joshi, H., MBBS, Galsky, M., Oh, W. K. & Tsao, C. K., Dec 2022, In: Discover Oncology. 13, 1, 73.

    Research output: Contribution to journal › Article › peer-review

    Open Access
    2 Scopus citations
View all 327 Research outputs
View all 157 press/media